NewcelX (NCEL) vs Radiopharm Theranostics (RADX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
NewcelX (NCEL) has outperformed Radiopharm Theranostics (RADX) over the past year, losing 83.4% versus a loss of 83.7%. Radiopharm Theranostics is the larger company by market cap ($16.8 million vs $16.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NCEL | RADX |
|---|---|---|
| Share price | $2.90 | $1.15 |
| Market cap | $16.72M | $16.78M |
| 1-day change | -4.61% | 0.00% |
| YTD return | +59.74% | -77.97% |
| 1-year return | -83.42% | -83.66% |
| 5-year return | -99.69% | — |
| P/E ratio (TTM) | 5.57 | — |
| EPS (TTM) | $0.52 | $-3.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.07 | $16.25 |
| 52-week low | $1.83 | $1.00 |
| Distance from 52-week high | -84.82% | -92.92% |
| Average volume | 12.22K | 84.62K |
| Shares outstanding | 5.78M | 14.59M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
NCEL vs RADX FAQ
Which is bigger, NewcelX or Radiopharm Theranostics?
Radiopharm Theranostics (RADX) is larger, with a market capitalization of $16.78M compared with $16.72M for NewcelX (NCEL).
Which stock has performed better over the past year, NCEL or RADX?
NCEL returned -83.42% over the past 12 months, compared with -83.66% for RADX (price return, excluding dividends). Past performance does not predict future results.
Are NewcelX and Radiopharm Theranostics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.